IL6 and rheumatoid arthritis: This is further reinforced by the fact that novel biotherapies (anti-TNF, anti-B cell, anti T-cell, or anti-IL-6) have only limited impact on chronic fatigue in RA [30] at least partly excluding the possibility that inflammatory factors directly cause this severe problem in RA.